Glaucoma Clinical Trials in Baltimore, Maryland
5 studies are recruiting for glaucoma in Baltimore, Maryland right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Study of Corneal Biomechanics in Glaucoma Patients Using Brillouin Microscopy
This pilot study evaluates the biomechanical properties of the cornea in glaucoma patients using Brillouin microscopy, a non-contact imaging technique. The study aims to compare corneal stiffness between patients with normal-tension glaucoma, high-tension glaucoma, and healthy controls, and to asse…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Maryland School of Medicine, Baltimore, Maryland
- Run by
- University of Maryland, Baltimore
-
Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial
Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial (DECLARE) is a multi-center, outcome-masked, randomized clinical trial. The purpose of this study is to compare glaucoma drainage device implantation in the anterior chamber (front part of the eye) and sulcus (small space between iris…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland
- Locations
- 8 in total
- Run by
- University of Pennsylvania
-
Optic Nerve Head Strain in Non-glaucoma Subjects
Persons who do not have glaucoma will have pictures taken of the optic nerve with a standard camera before and 2 weeks after starting to take a daily glaucoma eye drop to lower eye pressure. These data will be used to compare to the same procedure performed with glaucoma patients to study how glauc…
- Stage
- EARLY_Phase 1
- Ages
- 30 to 90
- Site
- Johns Hopkins Hospital, Baltimore, Maryland
- Run by
- Johns Hopkins University
-
Ocular Blood Flow Imaging for Glaucoma Assessment
The goal of this clinical trial is to investigate the use of an FDA-cleared retinal blood flow imaging instrument called the XyCAM RI and XyCAM FC (Vasoptic Medical, Inc., Columbia, MD) in glaucoma management. The main question it aims to answer are: * Can the investigators use blood flow to discri…
- Stage
- Not phased
- Ages
- 18 to 88
- Site
- University of Maryland Eye Associates at Redwood, Baltimore, Maryland
- Run by
- University of Maryland, Baltimore
-
Retinal Blood Flow and Autoregulation
The purpose of this study is to establish autoregulation of retinal blood flow in arterioles and capillaries as a biomarker for early primary open angle glaucoma.
- Stage
- Phase 4
- Ages
- 18 to 88
- Site
- University of Maryland Faculty Physicians, Inc, Baltimore, Maryland
- Locations
- 4 in total
- Run by
- University of Maryland, Baltimore
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.